目录:MedChemExpress LLC>>生化试剂>> SDMA | MCE
CAS | 30344-00-4 | 纯度 | ≥98.0% |
---|---|---|---|
分子量 | 202.25 | 分子式 | C₈H₁₈N₄O₂ |
供货周期 | 现货 | 规格 | 10 mg |
货号 | HY-101410 | 应用领域 | 医疗卫生,化工,生物产业,制药/生物制药 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 30344-00-4
产品活性:SDMA (Symmetric dimethylarginine) is an endogenous inhibitor of nitric oxide (NO) synthase activity.
研究领域:Metabolic Enzyme/Protease
作用靶点:Endogenous Metabolite
结构分类:酮、醛、酸
In Vitro: SDMA is the structural isomer of the cardiovascular risk marker asymmetric dimethylarginine, as an endogenous marker of renal function. SDMA does not directly inhibit NOS but is a competitor of arginine transport. SDMA is primarily eliminated by renal excretion and is a promising endogenous marker of glomerular filtration rate. SDMA inhibits dose dependently the NO synthesis in intact endothelial cells, whereas it has no effect on protein expression of NOS. SDMA is involved in the inflammatory process of chronic kidney disease, activating NF-κB and resulting in enhanced expression of IL-6 and TNF-α.
In Vivo: SDMA is highly stable in serum and plasma, and the assay demonstrates excellent analytical performance. In unaffected dogs, SDMA remains unchanged whereas in affected dogs, SDMA increases during disease progression, correlating strongly with an increase in sCr and decrease in GFR. Chronic SDMA infusion leads to a significant increase of SDMA levels in mice, but the GFR did not change at 4 weeks. No histological changes are observed, particularly no effect on fibrosis or endothelias nitric oxide synthase expression. There is neither an effect of SDMA on systolic blood pressure nor on ejection fraction.
相关产品:Natural Product Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | Natural Product Library | Human Endogenous Metabolite Compound Library | Food-Sourced Compound Library | Human Metabolite Library | D-Valine-d8 | D-α-Hydroxyglutaric acid disodium | Nicotinamide N-oxide | Deoxycholic acid-d5 | Doxorubicin-13C,d3 (TFA) | Palitantin | Estradiol hemihydrate | Adrenaline sulfate | Oleic acid-13C | Dextranase | H2S Donor 5a | Methylmalonic acid | Glycine, N-(aminoiminomethyl)-N-methyl-13C | Dihydroxyacetone phosphate | Sphingomyelin | (-)-Jasmonoyl-L-isoleucine | Octanoic acid-d2 | Vardenafil-d5 | N-Acetyllactosamine | D-Arabitol-13C | Imidazole | L-Tartaric acid diammonium | i-Inositol | Tryptophol | L-Aspartic acid | Indolelactic acid | 6-Mercaptopurine-13C2,15N | D-Sorbitol-d8 | Octanoic acid-d3 | Dinoprost-d4
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种*仅有化合物库,我们致力于为*科研客户提供前沿的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药 Patent 收录了MCE客户的科研成果;
• 专业团队跟踪新的制药及生命科学研究进展,为您提供*新的活性化合物;
• 与世界各大制药公司及*科研机构建立了长期的合作。